Keywords: Merck & Co, BGI, Biomarkers

Merck & Co explores collaboration with China’s BGI

Article | 17 September 2010

Print This

US drugs giant Merck & Co (NYSE: MRK), at a conference in Shenzhen, China, signed a statement of intent to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in